DMTs Linked to Cervical Lesion Risk & Tecfidera Lowers Risk of 1st Symptoms in RIS episode artwork

EPISODE · Nov 14, 2022 · 13 MIN

DMTs Linked to Cervical Lesion Risk & Tecfidera Lowers Risk of 1st Symptoms in RIS

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting on how exposure to high-efficacy DMTs is linked to an increased risk of cervical abnormalities in women with MS.He also reads another news article on Tecfidera reducing the risk of experiencing the first MS symptoms in adults with radiologically isolated syndrome.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published Nov 14, 2022

Embed this episode

NOW PLAYING

DMTs Linked to Cervical Lesion Risk & Tecfidera Lowers Risk of 1st Symptoms in RIS

0:00 13:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 13 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on November 14, 2022.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!